Elicio Therapeutics Inc. (ELTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $42.46M
Last updated: Nov 17, 2026 at 11:02 AM ET
Elicio Therapeutics Inc. (ELTX) Competitors
The companies most similar to Elicio Therapeutics are Werewolf Therapeutics (HOWL), Plus Therapeutics (PSTV) and OS Therapies (OSTX). By market cap, Elicio Therapeutics ranks 5th of the 13 companies on this page; Tiziana Life Sciences (TLSA) is the largest at $72.53M.
Peer Comparison
ELTX's ROIC of -96.6% is above the peer median of -109.2%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Elicio Therapeutics (ELTX) | $42.46M | N/A | N/A | 0.0% | -96.6% | 0.0% | 0.00% |
| Werewolf Therapeutics Inc (HOWL) | $47.64M | N/A | 2.3x | -164.8% | N/A | -100.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| OS Therapies Incorporated (OSTX) | $34.87M | N/A | N/A | 0.0% | 218.0% | 0.0% | 0.00% |
| Evaxion Biotech AS (EVAX) | $25.27M | N/A | 0.2x | -115.5% | -79.5% | -100.0% | 0.00% |
| Oncolytics Biotech Inc (ONCY) | $48.51M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Lite Strategy, Inc. (LITS) | $25.30M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rein Therapeutics Inc (RNTX) | $47.63M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mural Oncology plc (MURA) | $35.38M | N/A | N/A | 0.0% | -173.6% | 0.0% | 0.00% |
| CEL-SCI Corp (CVM) | $22.51M | N/A | N/A | 0.0% | -109.0% | -62.7% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Peer median | $35.13M | N/A | 2.2x | 0.0% | -109.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Elicio Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Werewolf Therapeutics Inc (HOWL) | Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. | HOWL competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| OS Therapies Incorporated (OSTX) | OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs... | OSTX competitors |
| Evaxion Biotech AS (EVAX) | Evaxion Biotech A / S, a clinical-stage artificial intelligence and immunology platform company... | EVAX competitors |
| Oncolytics Biotech Inc (ONCY) | Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer. | ONCY competitors |
| Lite Strategy, Inc. (LITS) | Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. | LITS competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Rein Therapeutics Inc (RNTX) | Rein Therapeutics Inc (RNTX) is a forward-thinking biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative disorders... | RNTX competitors |
| Mural Oncology plc (MURA) | Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors... | |
| CEL-SCI Corp (CVM) | CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. | CVM competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
Frequently Asked Questions About ELTX
Who are Elicio Therapeutics' main competitors?
The companies most similar to Elicio Therapeutics include Werewolf Therapeutics (HOWL), Plus Therapeutics (PSTV), OS Therapies (OSTX), Evaxion Biotech AS (EVAX) and Oncolytics Biotech (ONCY), listed from the closest match.
Who is Elicio Therapeutics' biggest competitor?
Tiziana Life Sciences (TLSA) is the largest of the similar companies at $72.53M; Werewolf Therapeutics (HOWL) is the closest match by business profile, size, sector and industry.
How does ELTX stock compare with its competitors?
ELTX's net margin is 0.0% against a peer median of 0.0%.
Which of Elicio Therapeutics' competitors pays a higher dividend?
Elicio Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Elicio Therapeutics bigger than its competitors?
No. Elicio Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Tiziana Life Sciences (TLSA) at $72.53M.
ELTX pages: Overview, Earnings, Forecast, Financials, Competitors